{"id":238821,"date":"2025-11-04T10:15:40","date_gmt":"2025-11-04T09:15:40","guid":{"rendered":"https:\/\/het-filter.de\/focus-on-nitrosamines-containment-and-filter-solutions-for-maximum-pharmaceutical-safety\/"},"modified":"2025-11-04T10:21:43","modified_gmt":"2025-11-04T09:21:43","slug":"focus-on-nitrosamines-containment-and-filter-solutions-for-maximum-pharmaceutical-safety","status":"publish","type":"post","link":"https:\/\/het-filter.de\/en\/focus-on-nitrosamines-containment-and-filter-solutions-for-maximum-pharmaceutical-safety\/","title":{"rendered":"Focus on nitrosamines: containment and filter solutions for maximum pharmaceutical safety"},"content":{"rendered":"\n

Nitrosamines have been a key quality and safety issue in the pharmaceutical industry for several years. The discovery of nitrosamine-containing impurities in active ingredients and medicines has led to stricter regulatory requirements worldwide. Pharmaceutical manufacturers must now prove that they are aware of, control and minimize nitrosamine risks throughout the entire manufacturing process. An important component of this is containment<\/a> and air filtration systems<\/g> that create stable, clean and reproducible process conditions. This is because the formation and unintentional introduction of nitrosamine-forming substances can only be effectively prevented with cleanly controlled processes. <\/p>\n\n

<\/div>\n\n
Nitrosamines: a challenge for the entire value chain<\/strong><\/h5>\n\n

Nitrosamines are formed when amines react with nitrosating reagents such as nitrite \u2013 and can occur as by-products or degradation products in pharmaceutical production processes. Typical causes are chemical reactions, raw material impurities, cleaning residues or cross-contamination between process steps. <\/p>\n\n

For the industry, this means: risk assessments, optimized synthesis routes, precise raw material control, analytical monitoring \u2013 and a controlled production environment<\/strong> that prevents accidental contact of potential precursors.<\/p>\n\n

\"Nitrosamines<\/figure>\n\n
<\/div>\n\n
The role of containment systems<\/strong><\/h5>\n\n

Containment<\/a> technologies such as RABS systems<\/strong> ensure that materials and air flows are controlled, processes are sealed off and cross-contamination is prevented. Unlike classic containment<\/a> scenarios, the focus with nitrosamines is not on protecting operating personnel from highly potent substances, but on product safety and process integrity<\/strong>. <\/p>\n\n

Suitable containment<\/a> systems make a decisive contribution here:<\/p>\n\n